SEC Form D · filed August 11, 2023
Nivagen Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Ashish C. Sevak · Paramus, NJDirectorRob C. Hart · San Francisco, CADirectorJaswinder Matharu · Douglas, Isle of Man, United KingdomDirectorRichard Cohan · Greenville, INDirectorDapeng Xu · New York, NYDirectorDasaradhi C. Lakkaraju · Sacramento, CAExecGopal C. Patel · Sacramento, CAExecJwalant Shukla · Sacramento, CAExec · DirectorPraneel C. Deo · Sacramento, CAExecMichael C. Kulper · Sacramento, CADirectorGarth Ebanks · Grand Cayman, Cayman IslandsDirectorCliff R. Brokaw · CHEVY CHASE, MDDirectorDasaradhi C. Lakkaraju · Sacramento, CAExecJaswinder Matharu · Douglas, Isle of Man, United KingdomDirectorGopal C. Patel · Sacramento, CAExecJwalant Shukla · Sacramento, CAExec · DirectorPraneel C. Deo · Sacramento, CAExecMichael C. Kulper · Sacramento, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗